
Tezspire Wins U.S. Approval for Nasal Polyps
Tezspire Secures U.S. FDA Approval for Chronic Rhinosinusitis with Nasal Polyps, Expanding Its Reach Beyond Severe Asthma AstraZeneca and Amgen have announced that their jointly developed biologic, Tezspire (tezepelumab), has received U.S. Food and Drug Administration (FDA) approval for the…












